DRD3, dopamine receptor D3, 1814

N. diseases: 199; N. variants: 13
Source: ALL
Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs6280
rs6280
Entrez Id: 1814
Gene Symbol: DRD3
DRD3
CUI: C3714760
Disease:
Drug-induced tardive dyskinesia
0.100 GeneticVariation BEFREE The meta-analysis comprising 1291 East Asian subjects also showed no association between the polymorphism and TD; the Mantel-Haenszel pooled OR for TD among carriers of the DRD3 Ser9Gly of the eight Asian studies was 0.94 (95% CI: 0.78-1.12). 22172931 2012
dbSNP: rs6280
rs6280
Entrez Id: 1814
Gene Symbol: DRD3
DRD3
CUI: C3714760
Disease:
Drug-induced tardive dyskinesia
0.100 GeneticVariation BEFREE We conclude that there is no or little association between DRD3 rs6280 polymorphisms and prevalence of TD. 19358223 2010
dbSNP: rs6280
rs6280
Entrez Id: 1814
Gene Symbol: DRD3
DRD3
CUI: C3714760
Disease:
Drug-induced tardive dyskinesia
0.100 GeneticVariation BEFREE Thus, a number of studies have focused on the association of dopamine system gene polymorphisms and TD, with the most consistent findings being an association between TD and the Ser9Gly polymorphism of the DRD3 gene and the TaqIA site 3' of the DRD2 gene. 19238168 2009
dbSNP: rs6280
rs6280
Entrez Id: 1814
Gene Symbol: DRD3
DRD3
CUI: C3714760
Disease:
Drug-induced tardive dyskinesia
0.100 GeneticVariation BEFREE This study investigated the possible relationship between TD and the polymorphisms Ser9Gly (DRD3), 102T>C (HTR2A), -1438G>A(HTR2A) and Cys23Ser (HTR2C) in African-Caribbean inpatients. 18562401 2009
dbSNP: rs6280
rs6280
Entrez Id: 1814
Gene Symbol: DRD3
DRD3
CUI: C3714760
Disease:
Drug-induced tardive dyskinesia
0.100 GeneticVariation BEFREE Search for these determinants has led to a few consensus associations of CYP2D6 *10, CYP1A2*1F, DRD2 Taq1A (rs1800497), DRD3 Ser9Gly (rs6280) and MnSOD Ala9Val (rs4880) variants with TD. 18781856 2008
dbSNP: rs6280
rs6280
Entrez Id: 1814
Gene Symbol: DRD3
DRD3
CUI: C3714760
Disease:
Drug-induced tardive dyskinesia
0.100 GeneticVariation BEFREE Antipsychotic-induced tardive dyskinesia and the Ser9Gly polymorphism in the DRD3 gene: a meta analysis. 16513329 2006
dbSNP: rs6280
rs6280
Entrez Id: 1814
Gene Symbol: DRD3
DRD3
CUI: C3714760
Disease:
Drug-induced tardive dyskinesia
0.100 GeneticVariation BEFREE Two gene variants appeared to be significant after adding them to the clinical regression models: (1) Ser9Gly DRD3 polymorphism was associated with severe TD (odds ratio for patients with 1 mutant allele when compared with individuals with 2 wild types was 2.5, 95% confidence interval 1.1-5.6, whereas the odds ratio for patients with 2 mutant alleles when compared with individuals with 1 mutant was 2.8, 95% confidence interval 1.0-7.4), and (2) GSTM1 absence was associated with TD (odds ratio 1.7, 95% confidence interval 1.2-2.4) particularly in white women. 16160620 2005
dbSNP: rs6280
rs6280
Entrez Id: 1814
Gene Symbol: DRD3
DRD3
CUI: C3714760
Disease:
Drug-induced tardive dyskinesia
0.100 GeneticVariation BEFREE In this study, we examined the association between the DRD3 ser9gly and BDNF val66met genetic polymorphisms and TD occurrence in 216 schizophrenic patients (TD/non-TD = 102/114). 15626824 2004
dbSNP: rs6280
rs6280
Entrez Id: 1814
Gene Symbol: DRD3
DRD3
CUI: C3714760
Disease:
Drug-induced tardive dyskinesia
0.100 GeneticVariation BEFREE We investigate the association of the polymorphism of the Ser311Cys and Ser9Gly of the dopamine D2 (DRD2) and D3 receptor (DRD3) genes respectively with TD in Chinese patients with schizophrenia. 12497614 2003
dbSNP: rs6280
rs6280
Entrez Id: 1814
Gene Symbol: DRD3
DRD3
CUI: C3714760
Disease:
Drug-induced tardive dyskinesia
0.100 GeneticVariation BEFREE Chinese Han patients with schizophrenia were assessed for abnormal involuntary movements, and subgroups of 42 patients with persistent tardive dyskinesia and 59 consistently without dyskinesias were assessed for the DRD3 ser9gly and the MnSOD ala-9val polymorphisms. 12960753 2003
dbSNP: rs6280
rs6280
Entrez Id: 1814
Gene Symbol: DRD3
DRD3
CUI: C3714760
Disease:
Drug-induced tardive dyskinesia
0.100 GeneticVariation BEFREE However, there was no significant allelic association of the Ser9Gly allele with TD (chi2 = 0.288, d.f. 12109967 2002
dbSNP: rs6280
rs6280
Entrez Id: 1814
Gene Symbol: DRD3
DRD3
CUI: C3714760
Disease:
Drug-induced tardive dyskinesia
0.100 GeneticVariation BEFREE These findings support a small but significant contribution of the DRD3 ser9gly polymorphism to TD susceptibility that is demonstrable over and above population effects and the effect of age and gender on the phenotype. 12062911 2002
dbSNP: rs6280
rs6280
Entrez Id: 1814
Gene Symbol: DRD3
DRD3
CUI: C3714760
Disease:
Drug-induced tardive dyskinesia
0.100 GeneticVariation BEFREE Association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients. 11490179 2001
dbSNP: rs6280
rs6280
Entrez Id: 1814
Gene Symbol: DRD3
DRD3
CUI: C3714760
Disease:
Drug-induced tardive dyskinesia
0.100 GeneticVariation BEFREE The dopamine D3 receptor gene (DRD3) ser9gly polymorphism has been previously associated with susceptibility to TD. 11140333 2000
dbSNP: rs6280
rs6280
Entrez Id: 1814
Gene Symbol: DRD3
DRD3
CUI: C3714760
Disease:
Drug-induced tardive dyskinesia
0.100 GeneticVariation BEFREE We found a high frequency (22-24%) of homozygosity for the Ser9Gly variant (allele 2) of the DRD3 gene among subjects with TD in both a cross-sectional and a longitudinal evaluation, as compared with the relative under-representation (4-6%) of this genotype in patients with no or fluctuating TD. 9106238 1997